Highline Capital Management, L.P. Alector, Inc. Call Options Transaction History

Highline Capital Management, L.P.

  • $0
  • Q4 2022

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2021

May 17, 2021
SELL
$14.84 - $22.23 $733,096 - $1.1 Million
-49,400 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$9.4 - $16.7 $240,640 - $427,520
-25,600 Reduced 34.13%
49,400 $747,000
Q3 2020

Nov 16, 2020
BUY
$10.54 - $24.96 $790,499 - $1.87 Million
75,000 New
75,000 $790,000

Others Institutions Holding ALEC

# of Institutions
166
Shares Held
58M
Call Options Held
57K
Put Options Held
14.9K
View Full List

About Alector, Inc.

ALEC Quotes by TradingView
  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $406M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Highline Capital Management, L.P. Portfolio

Follow Highline Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Highline Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Highline Capital Management, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email